ArticleThe Lancet regional health. Europe2025
Respiratory syncytial virus prophylaxis with nirsevimab: impact beyond hospitalisations.
Cristina Calvo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it